Search Results 2331-2340 of 17712 for rheumatoid arthritis
D., focused on bone morphogenic protein-2 (BMP-2), a growth factor that has been used to regenerate large fractures and bone loss. However, high doses are ...
The team targets new and unique transcription factor candidates and noncoding elements of the genome to functionally validate their roles in drug sensitivity.
Kalaaji AN, McCullough K, Hay JB. The enhancement of lymphocyte localization in skin sites of sheep by tumor necrosis factor alpha. Immunol Lett. 1989 Dec; 23(2): ...
Taking anti-rheumatic disease medication (including methotrexate or other antimetabolites) within 3 months prior to study enrollment. On chronic ...
RO7790121 is a fully human immunoglobulin G1 monoclonal antibody (mAb) against tumor necrosis factor-like ligand 1A (TL1A). TL1A plays a central role in the ...
chronic back pain, or arthritic. At the time of enrollment subject has no restrictions to exercise and will sign a form stating they have received approval ...
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II ...
... Arthritis, Herniated disk, Neck pain, Cervical spondylosis, Amyotrophic lateral sclerosis, Myelopathy, Paraparesis, Dystonia, Charcot-Marie-Tooth disease ...
Arthritis Care Res (Hoboken). 2021 Aug; 73 (8):1106-1113 Epub 2021 July 14. View PubMed; Wiedmeier JE, Mountjoy LJ, Buras MR, Kosiorek HE, Coppola KE, Verona ...
Factor analysis of the eating disorder diagnostic scale in individuals with bipolar disorder. Eat Behav. 2019 Apr; 33:30-33 Epub 2019 Feb 18. View PubMed ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your Annual Fund gift can drive advancements in cancer care.